BVMF/S1RP34 (BVMF/S1RP34)

Brazil Stock Exchange: BVMF/S1RP34 · BRL

R$5.25

+0.35 (+7.1%)· Recorded snapshot

Market cap	11B
Revenue (ttm)	10.2B
Net income (ttm)	-708.3M
EPS (ttm)	-R$0.35
P/E (forward)	11.7x
Volume	14
Beta	0.38

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 10.2B
Net income (ttm): -708.3M
EPS (ttm): -R$0.35
P/E (forward): 11.7x
Market cap: 11B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/E11.7

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-9.5

P25 n/aP50 n/aP75 n/a

ROIC-3.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/S1RP34 indicators

Market & fundamental data

Available fields

192

Groups with data

Currency

USD

Showing 192 of 192 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-11-05
Employees	835
Employees change	-537
Employees growth	-39.14%
Enterprise value	BRL 12.5B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1980
Industry	Biotechnology
Is primary listing	No
ISIN number	BRS1RPBDR005
Last earnings date	2026-08-05
Last refreshed	2026-10-30
Market cap	BRL 11B
Next earnings date	2026-11-05
Price	BRL 5.25
Price currency	BRL
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-29
Symbol	bvmf/S1RP34
Website	https://www.sarepta.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-6.75%
EV/EBITDA	15.34x
EV/FCF	29.42x
EV/Sales	1.17x
FCF / EV yield	3.4%
FCF yield	3.86%
Forward P/E	11.66x
P/(OCF - SBC) ratio	174.02x
P/B ratio	1.39x
P/FCF ratio	25.93x
P/OCF ratio	19.12x
P/S ratio	1.07x
Price / tangible book value	1.42x
Sector forward P/E	10.79x
Sector P/E	32.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-3.15%
EBITDA margin	-0.89%
FCF margin	3.99%
Gross margin	19.11%
Operating margin	-3.15%
Pretax margin	-6.63%
Profit margin	-6.93%
Profit per employee	BRL -848,317
Revenue per employee	BRL 12.2M
ROA	-1.13%
ROA (5Y)	-6.49%
ROCE	-2.32%
ROE	-9.48%
ROE (5Y)	-55.33%
ROIC	-3.36%
SBC / revenue	5%
Tax / revenue	0.29%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
FCF growth (Q)	-14.39%
Gross profit growth	-33.24%
Gross profit growth (Q)	-36.8%
Net income growth years	0
OCF growth (Q)	-24.59%
Operating income growth (Q)	-54.76%
Revenue growth	-20.44%
Revenue growth (Q)	-34.34%
Revenue growth (QoQ)	-45.09%
Revenue growth 10Y	108.81%
Revenue growth 3Y	25.31%
Revenue growth 5Y	26.89%
Revenue growth years	10

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -151.1M
Depreciation and amortization	BRL 240.8M
EBIT	BRL -322.4M
EBITDA	BRL -90.8M
EPS	BRL -0.35
Financing cash flow	BRL -812.1M
Free cash flow	BRL 424M
Free cash flow minus SBC	BRL -87.9M
Gross profit	BRL 2B
Income taxes	BRL 30.1M
Investing cash flow	BRL 522.5M
Net borrowing	BRL -856.8M
Net cash flow	BRL 285.4M
Net income	BRL -708.3M
Operating cash flow minus SBC	BRL 63.2M
Operating income	BRL -322.4M
Revenue	BRL 10.2B
Stock-based compensation	BRL 511.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-0.07
Book value per share	BRL 74.94
Debt / EBITDA	7.07
Debt / equity	0.7
Debt / FCF	12.98
Interest coverage	-0.87
Long-term assets	BRL 4.5B
Long-term liabilities	BRL 5.9B
Net cash (debt)	BRL -1.4B
Net cash / market cap	-12.91%
Net debt / equity	0.18
Net debt / FCF	3.35
Piotroski F-Score	4
Property, plant and equipment	BRL 2.4B
Shareholders' equity	BRL 7.9B
Tangible book value	BRL 7.8B
Tangible book value per share	BRL 73.44
Total assets	BRL 16.5B
Total cash	BRL 4.1B
Total debt	BRL 5.5B
Total liabilities	BRL 8.6B
WACC	5.98%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.57
Current assets	BRL 12B
Current liabilities	BRL 2.7B
Current ratio	4.42
Inventory turnover	1.68
Net working capital	BRL 4.9B
Quick ratio	2.44
Working capital	BRL 8.9B
Working capital turnover	5.92

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-7.36%
Shareholder yield	-7.36%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 4.76
1D price change	7.14%
1M price change	1.24%
1M total return	1.24%
1W price change	4.7%
1W total return	4.7%
1Y price change	-22.83%
1Y return CAGR	-22.85%
1Y total return	-22.83%
20-day SMA	BRL 4.55
200-day SMA	BRL 4.93
3M price change	16.95%
3M total return	16.95%
3Y price change	-83.53%
3Y return CAGR	-45.18%
3Y total return	-83.53%
50-day SMA	BRL 4.95
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 6.65
52-week high date	2025-11-03
52-week low	BRL 3.75
52-week low date	2026-08-03
5Y price change	-78.28%
5Y return CAGR	-26.32%
5Y total return	-78.28%
6M price change	-6.31%
6M total return	-6.31%
All-time high	BRL 45.78
All-time high date	2024-06-21
All-time low	BRL 2.88
All-time low date	2025-07-24
Average true range (ATR)	BRL 0.21
Average volume	3.5K
Beta (5Y)	0.38
Change from 52-week high	-21.05%
Change from 52-week low	40%
Change from all-time high	-89.3%
Change from all-time low	70.14%
Change from open	-0.19%
Day's gap	7.35%
Dollar volume	BRL 73.5
High price	BRL 5.26
Low price	BRL 5.23
Monthly RSI	34.05
Open price	BRL 5.26
Position in 52-week range	66.67%
Previous close	BRL 4.90
Price vs 150-day SMA	3.05%
Price vs 20-day SMA	7.81%
Price vs 200-day SMA	-0.51%
Price vs 50-day SMA	-0.97%
Relative volume	0
RSI	54.31
Sharpe ratio	0.38
Sharpe ratio (3Y)	-0.18
Sortino ratio	0.63
Sortino ratio (3Y)	-0.19
Volume	14
Weekly RSI	49.9
YTD price change	-18.06%
YTD total return	-18.06%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	100.5M
Shares change (QoQ)	-13.52%
Shares change (YoY)	7.36%
Shares held by insiders	4.78%
Shares held by institutions	102.5%
Short ratio	7.6 days

Deeper analysis on BVMF/S1RP34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/S1RP34 report

Is a complete BVMF/S1RP34 research report available?

No complete published report is available for bvmf/S1RP34 (BVMF/S1RP34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/S1RP34 (BVMF/S1RP34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/S1RP34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/S1RP34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/S1RP34

Frequently asked questions